Real-world evidence that erectile dysfunction drugs may have cardioprotective properties

Written by Linda Essex
Cardiopulmonary and vascular Editorials Medical devices, pharmaceuticals and vaccines Outcomes research Real-world evidence

Lower incidence of major adverse cardiovascular events is associated with taking erectile dysfunction drugs in a large US RWD study of a broad population of men  A large RWD study showing reduced incidence of major adverse cardiovascular events (MACE) and heart-related mortality amongst men taking erectile dysfunction (ED) drugs has been published in the January 2023 issue of the Journal of Sexual Medicine. The research comprises a retrospective observational study based on health records and was conducted by scientists from Huntington Medical Research Institutes (HMRI) in Pasadena, HealthCore, Inc., and the University of California in San Francisco. The study is...

To view this content, please register now for access

It's completely free